Showing results (601-610 of 1,787) with videos related to

Sort By:
Pageof 179
Hepatology Communications|December 28, 2021
Serum Proteomics Uncovers Biomarkers of Clinical Portal Hypertension in Children With Biliary AtresiaJulie Osborn, Reena Mourya, Unmesha Thanekar, et al.
Hepatology Communications|September 14, 2022
Liver steatosis and fibrosis in people with human immunodeficiency virus in West Africa and the relationship with hepatitis B virus coinfectionGiovanni Villa, Dorcas Owusu, Colette Smith, et al.
Hepatology Communications|September 16, 2022
Vasor: Accurate prediction of variant effects for amino acid substitutions in multidrug resistance protein 3Annika Behrendt, Pegah Golchin, Filip König, et al.
Hepatology Communications|October 25, 2022
Outcomes of subjects who are lean, overweight or obese with nonalcoholic fatty liver disease: A cohort study in ChinaYanqi Lan, Ying Lu, Jinfeng Li, et al.
Hepatology Communications|November 2, 2022
NPRL2 down-regulation facilitates the growth of hepatocellular carcinoma via the mTOR pathway and autophagy suppressionYa-Chin Wang, Ming-Chao Tsai, Yaw-Sen Chen, et al.
Hepatology Communications|November 4, 2022
Leveraging COVID-19 vaccination to promote hepatitis C screeningAaron Vanderhoff, David Smookler, Mia J Biondi, et al.
Hepatology Communications|September 4, 2025
Electronic decision aids enhance management of primary care patients with steatotic liver disease: Proof of concept pilot studyAshley Spann, Kristy Bishop, Sarah Marbach, et al.
Hepatology Communications|September 4, 2025
Changing landscape of steatotic liver diseases and liver fibrosis in the United States during the COVID-19 pandemicAbdelrahman M Attia, Mohammad Saeid Rezaee-Zavareh, Yee Hui Yeo, et al.
Hepatology Communications|August 29, 2025
Arachidonic acid metabolism in metabolic dysfunction-associated steatotic liver disease and liver fibrosisYufang Ma, Jingsun Jiang, Chong Zhao, et al.
Hepatology Communications|August 25, 2021
In Vitro Model for a Drug Assessment of Cytochrome P450 Family 3 Subfamily A Member 4 Substrates Using Human Induced Pluripotent Stem Cells and Genome Editing TechnologySayaka Deguchi, Tomohiro Shintani, Kazuo Harada, et al.
Pageof 179